Cerner Corporation (NASDAQ:CERN) President Zane Burke stated in February that the company was entering 2017 "with a strong competitive position, a significant pipeline, and a solid growth outlook." This optimism was reinforced by Cerner's projection of year-over-year adjusted earnings growth of nearly 19% in the first quarter.
The healthcare technology company announced its first-quarter results after the market closed on Thursday. Did Cerner's sunny outlook prove accurate? Here are the highlights.
Cerner results: The raw numbers
|$1.26 billion||$1.14 billion||
Net income from continuing operations
|$173.2 million||$150.4 million||
What happened with Cerner this quarter?
Cerner enjoyed solid growth in system sales. Revenue from sales of new systems increased 14.5% year over year to $319.9 million. Revenue from support, maintenance, and services rose 9.4% from the prior year period to $918.2 million. Revenue stemming from reimbursed travel increased 17% year over year to $22.4 million. Cerner's total revenue came in at the high end of the guidance range provided previously.
The company's bottom-line improvement was even better. Cerner kept costs under control, with total operating expenses in the first quarter of $817.4 million, up 9.4% from the prior year period. General and administrative expenses actually declined almost 2% from the first quarter of last year to $88.4 million. As a result, Cerner was able to post earnings at the high end of its guidance range.
Bookings (the amount of prospective revenue from contracts signed but not yet implemented) in the first quarter totaled $1.25 billion. That reflected a 7% increase from the prior year period and was above the midpoint of Cerner's guidance range.
Cerner reported first-quarter operating cash flow of $303.6 million, with free cash flow of $144.4 million. Days sales outstanding in the first quarter was 71 days, down from 76 days in the same quarter of 2016. The company's total backlog stood at just over $16 billion, up 10% year over year.
What management had to say
Commenting on his company's first-quarter performance, Cerner president Zane Burke said, "Our first-quarter results represent a strong start to the year, with all key metrics at or above expected levels. Our results again included a significant number of new client wins, reflecting our strong competitive position and an active marketplace."
Cerner projects second-quarter revenue between $1.265 billion and $1.335 billion. Adjusted diluted earnings per share in the second quarter are expected to come in between $0.60 and $0.62.
For the full-year 2017, Cerner projects revenue in the range of $5.1 billion to $5.3 billion and adjusted diluted earnings per share between $2.44 and $2.56. Both ranges are consistent with previously provided guidance. The company also expects second-quarter bookings will be between $1.3 billion and $1.5 billion.
Cerner continues to attract new customers, with recent wins including St. Joseph's Healthcare System in New Jersey and Pomona Valley Hospital Medical Center in California. The healthcare technology provider is also gaining additional ground with existing customers. For example, longtime customer Palmetto Health in South Carolina recently expanded Cerner's revenue cycle management software across four of its acute facilities.
The company's business appears to be in solid shape for the future. Recurring revenue from support, maintenance, and services gives Cerner a reliable revenue stream. And although there are no longer federal incentives for healthcare providers to adopt new technology, plenty of opportunities remain for Cerner to attract new customers that are unhappy with their current systems.
More from The Motley Fool
Why Shares of Cerner Corp. Are Down Today
Third-quarter results fell short of expectations, but the company sees business picking back up in the fourth quarter.
Cerner Corporation Unimpressive in 3rd Quarter, but Expects Better Days Ahead
The healthcare technology company reports so-so growth and lower bookings than expected.
Cerner Corporation Meets Expectations in Second Quarter With Solid Recurring Revenue
The healthcare technology company did what it needed to do in the second quarter.